A new mobile website, DROPS101 Web Tools (Alcon), offers digital access to product information for moxifloxacin related to the treatment of bacterial conjunctivitis in children.
Fort Worth, TX-A new mobile website, DROPS101 Web Tools, takes the interaction between patients and health-care providers into the digital age by providing a one-stop, educational resource about commonly prescribed pediatric eye and ear treatments. Alcon is launching the site in response to growing demand for digital access to patient-centered materials.
The site offers digital access to product information related to the treatment of two extremely common child ailments: moxifloxacin HCI ophthalmic solution 0.5% (Moxeza) for the treatment of bacterial conjunctivitis caused by susceptible strains and ciprofloxacin 0.3% and dexamethasone 0.1% (Ciprodex Otic) for the treatment of acute otitis externa.
“We heard from doctors that patients need a one-click resource for prescribed eye and ear treatments. [The site] is another way we are expanding our commitment to meet the ever-evolving needs of health-care professionals and their patients,” said Amy Patyk, multi-channel marketing manager, Alcon U.S. “By offering mobile access to educational tools, health-care professionals can help their patients learn more about medication options and treatment support with the convenience of wireless technology.”
DROPS101 Web Tools are available in the United States only. For more information, medical providers or healthcare professionals can contact their Alcon sales representative or visit www.drops101.com.
For more articles in this issue of Ophthalmology Times eReport, click here.